Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Amgen Inc
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Hims & Hers Health Inc Business News Economy
From CNBC.com News
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
Tags US: News Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Social issues Health care industry Novo Nordisk A/S
From CNBC.com News
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Tags Business Health Insurance Health insurance
From CNBC.com News
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Business
From CNBC.com News
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Pharmaceuticals Novo Nordisk A/S Breaking News: Europe
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Europe Politics Novo Nordisk A/S Politics
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Politics Novo Nordisk A/S Biotechnology
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Healthy Returns
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Trade Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Make It: Next Gen Investing Make It / Money Make It
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Technology Novo Nordisk A/S Internet
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags CVS Health Corp Cloudflare Inc Palantir Technologies Inc
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Merck & Co Inc LILLY DRN Pharmaceuticals
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags LILLY DRN Health & Science Companies
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Biotechnology Health care industry Breaking News: Business
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Biotechnology Health care industry Breaking News: Business
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Health care industry Social issues Centene Corp
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Stellantis NV Autos Earnings
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Business
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags Asia Markets UBS Group AG Morgan Stanley
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags LILLY DRN Health & Science Companies
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Novo Nordisk A/S Economy Trade
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Business Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags World Economy U/S/ Economy World economy
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Pharmaceuticals Bavarian Nordic A/S Novartis AG
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Business Novo Nordisk A/S Science
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags LILLY DRN Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Biotechnology Biotech and Pharmaceuticals LILLY DRN
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.